HHS Privacy Regs Need FDA Clarification Guidance, Attorney Suggests
Executive Summary
The application of HHS patient privacy regulations to ongoing clinical research overseen by FDA is one of five areas that need agency guidance and clarification, Hogan & Hartson attorney Robert Brady said at the Food & Drug Law Institute annual educational conference April 19.